DrugPatentWatch Database Preview
Akorn Company Profile
What is the competitive landscape for AKORN, and what generic alternatives to AKORN drugs are available?
AKORN has one hundred and sixty-eight approved drugs.
There is one US patent protecting AKORN drugs. There are three tentative approvals on AKORN drugs.
Summary for Akorn
| US Patents: | 1 |
| Tradenames: | 133 |
| Ingredients: | 122 |
| NDAs: | 168 |
| Patent Litigation for Akorn: | See patent lawsuits for Akorn |
| PTAB Cases with Akorn as petitioner: | See PTAB cases with Akorn as petitioner |
Drugs and US Patents for Akorn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn Inc | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 079078-001 | Sep 14, 2009 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Akorn Inc | DRONABINOL | dronabinol | CAPSULE;ORAL | 079217-001 | Jun 20, 2014 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Akorn | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 204589-001 | Apr 18, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Akorn Inc | NAPHAZOLINE HYDROCHLORIDE | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 083590-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Akorn | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | INJECTABLE;INJECTION | 078228-001 | Apr 14, 2010 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Akorn | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 087969-001 | Nov 10, 1983 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Akorn Inc | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 207926-001 | Jan 15, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Akorn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Akorn | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | 4,167,574 | ➤ Sign Up |
| Akorn | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | 3,998,834 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Akorn Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2008014036 | ➤ Sign Up |
| European Patent Office | 2043601 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Akorn Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 00117 | Netherlands | ➤ Sign Up | PRODUCT NAME: DEXMEDETOMIDINE, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH IN FARMACEUTISCH OPZICHT AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZ ONDER DEXMEDETOMIDINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/2/02/033/001 20020830 |
| C/GB98/040 | United Kingdom | ➤ Sign Up | PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508 |
| C0042 | Belgium | ➤ Sign Up | PRODUCT NAME: CHLORHYDRATE DE ROPIVACAINE MONOHYDRATE; NAT. REGISTRATION NO/DATE: 212 IS 216 F 12 19960806; FIRST REGISTRATION: SE 12319 19950915 |
| C0035 | France | ➤ Sign Up | PRODUCT NAME: ZOLEDRONIC ACID; NAT REG. NO/DATE: EU/1/01/176/001 20010320; FIRST REG.: LI IKS N 55 463 20001128 |
| 1273292/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC 58751 28.05.2009 |
| C/GB07/011 | United Kingdom | ➤ Sign Up | PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003 |
| C0025 | Belgium | ➤ Sign Up | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
